"Aethlon Medical treats first subject with Hemopurifier device in Australia" was originally created and published by Medical Device Network, a GlobalData owned brand.

AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed ...

The European Automobile Manufacturers' Association (ACEA), representing 16 car and truck makers, said this week that its ...

AdventHealth broke ground for a new hospital that will be built in Aurora near E-470 in the Highlands community.

Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious ...

Aethlon is trading up today, currently at $0.6930, up 0.0700, gaining 11.1643% on over 2.1 Million shares. The stock has a ...

Mangaluru: Dakshina Kannada and Udupi districts are witnessing a notable increase in the presence of electric vehicles, both ...

BUENOS AIRES (Reuters) - Argentina next week will lift import tariffs on some low-cost electric and hybrid vehicles, while ...

UofL Hospital Environmental Services (EVS) received top honors as the winner of Crothall Healthcare’s National Account of the ...

Police believe the car went off the road on a bend and hit a tree sidewise, splitting the car into two pieces. One man was ...

Several Palestinian prisoners released by Israel arrived this Saturday at the European Hospital in Jan Yunis, in the southern ...